Item 1A. Risk Factors
Item 1A.
Risk Factors
There have been no material changes during the
nine months ended April 30, 2022 to the risk factors discussed in our Annual Report on Form 10-K for the year ended July 31, 2021.
If any of the identified risks actually occur, our business, financial condition and results of operations could suffer. The trading price
of our common stock could decline and you may lose all or part of your investment in our common stock. The risks and uncertainties described
in our Annual Report on Form 10-K for the year ended July 31, 2021 are not the only ones we face. Additional risks that we currently
do not know about or that we currently believe to be immaterial may also impair our business operations.
Item 6.
Exhibits
The following exhibits are filed herewith and this list constitutes
the exhibit index.
Exhibit Number
Exhibit Description
10.1
Form of Subscription Agreement dated April 14, 2022 between Odyssey Health, Inc. and certain purchasing security holders.
10.2
Form of Stock Purchase Agreement dated April 14, 2022 between Odyssey Health, Inc. and certain purchasing security holders.
10.3
Form of Warrant Agreement dated April 14, 2022 between Odyssey Health, Inc. and certain purchasing security holders.
10.4
Form of Registration Rights Agreement dated April 14, 2022 between Odyssey Health, Inc. and certain purchasing security holders.
10.5
Form of Amendment to Promissory Note dated April 20, 2022 between Odyssey Health, Inc. and various officers and directors.
10.6
Amendment to Convertible Promissory Note dated March 31, 2022 between Odyssey Health, Inc. and Tysadco Partners, LLC. Incorporated to Exhibit 10.1 to Form 8-K filed April 14, 2022.
10.7
Amendment to Convertible Promissory Note dated February 1, 2022 between Odyssey Health, Inc. and LGH Investments, LLC. Incorporated to Exhibit 10.1 to Form 8-K filed February 18, 2022.
10.8
Form of Amendment to Promissory Note dated June 4, 2022 between Odyssey Health, Inc. and various officers and directors.
10.9
Amendment to Convertible Promissory Note dated June 10, 2022 between Odyssey Health, Inc. and LGH Investments, LLC.
31.1
Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934
31.2
Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934
32.1
Certification of Chief Executive Officer pursuant to Section 1350
32.2
Certification of Chief Financial Officer pursuant to Section 1350
101.INS
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH
Inline XBRL Taxonomy Extension Schema Document
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover Page Interactive Data File (formatted in inline XBRL, and included in exhibit 101).
* Management or compensatory agreement.
23
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized,
as of June 14, 2022.
ODYSSEY HEALTH, INC.
(f/k/a ODYSSEY GROUP INTERNATIONAL,
INC.)
By:
/s/ Joseph Michael Redmond
Joseph Michael Redmond
Chief Executive Officer, President and Director
(Principal Executive Officer)
By:
/s/ Christine M. Farrell
Christine M. Farrell
Chief Financial Officer
(Principal Financial and Accounting Officer)
24